[1. De Braekeleer E, Douet-Guilbert N, Le Bris MJ, Basinko A, Morel F, De Braekeleer M. Gene expression profiling of adult t(4;11)(q21;q23)-associated acute lymphoblastic leukemia reveals a different signature from pediatric cases. Anticancer Res. 2012 Sep;32(9):3893-9]Search in Google Scholar
[2. De Braekeleer M, Morel F, Le Bris MJ, Herry A, Douet-Guilbert N. The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia. Anticancer Res. 2005 May-Jun;25(3B):1931-44]Search in Google Scholar
[3. Drexler HG, Quentmeier H, MacLeod RA. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations. Leukemia. 2004 Feb;18(2):227-3210.1038/sj.leu.2403236]Search in Google Scholar
[4. Super HG, Strissel PL, Sobulo OM, Burian D, Reshmi SC, Roe B, Zeleznik-Le NJ, et al. Identification of complex genomic breakpoint junctions in thet(9;11) MLL-AF9 fusion gene in acute leukemia. Genes Chromosomes Cancer. 1997 Oct;20(2):185-9510.1002/(SICI)1098-2264(199710)20:2<185::AID-GCC9>3.0.CO;2-#]Search in Google Scholar
[5. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med. 1998 Aug 27;339(9):605-1510.1056/NEJM199808273390907]Search in Google Scholar
[6. Pui CH, Kane JR, Crist WM. Biology and treatment of infant leukemias. Leukemia. 1995 May;9(5):762-9]Search in Google Scholar
[7. Ludwig W D, Rieder H, Bartram C R, Heinze B, Schwartz S, Gassmann W, et al. Immunophenotypic and genotypic features, clinical characteristics and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL03/87 and 04/89. Blood 1998; 92:1898-1909]Search in Google Scholar
[8. van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 1999 Dec;13(12):1901-2810.1038/sj.leu.2401592]Search in Google Scholar
[9. Felix CA, Hosler MR, Slater DJ, Parker RI, Masterson M, Whitlock JA, et al. MLL genomic breakpoint distribu- tion within the breakpoint cluster region in de novo leukemia in children. J Pediatr Hematol Oncol. 1998 Jul- Aug;20(4):299-30810.1097/00043426-199807000-00004]Search in Google Scholar
[10. Reichel M, Gillert E, Angermüller S, Hensel JP, Heidel F, Lode M, et al. Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL. Oncogene. 2001 May 24;20(23):2900-710.1038/sj.onc.1204401]Search in Google Scholar
[11. Muñoz L, Nomdedéu JF, Villamor N, Guardia R, Colomer D, Ribera JM, et al. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells. Leukemia. 2003 Jan;17(1):76-8210.1038/sj.leu.2402708]Search in Google Scholar
[12. Marcucci G, Strout MP, Bloomfield CD, Caligiuri MA. Detection of unique ALL1 (MLL) fusion transcripts in normal human bone marrow and blood: distinct origin of normal versus leukemic ALL1 fusion transcripts. Cancer Res. 1998 Feb 15;58(4):790-3]Search in Google Scholar
[13. Jansen MW, Corral L, van der Velden VH, Panzer- Grümayer R, Schrappe M, Schrauder A, et al. Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia. 2007 Apr;21(4):633-4110.1038/sj.leu.2404578]Search in Google Scholar
[14. Hagemeijer A, van Dongen JJ, Slater RM, van't Veer MB, Behrendt H, Hählen K, et al. Characterization of the blast cells in acute leukemia with translocation (4;11): report of eight additional cases and of one case with a variant translocation. Leukemia. 1987 Jan;1(1):24-3]Search in Google Scholar
[15. Gleissner B, Goekbuget N, Rieder H, Arnold R, Schwartz S, Diedrich H, et al. CD10- pre-B acute lymphoblastic leukemia (ALL) is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations: results of the German Multicenter Trials for Adult ALL (GMALL). Blood. 2005 Dec 15;106(13):4054-610.1182/blood-2005-05-1866]Search in Google Scholar
[16. Abdelhaleem M. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia. Exp Mol Pathol. 2007 Aug;83(1):138-4110.1016/j.yexmp.2007.02.004]Search in Google Scholar
[17. Supriyadi E, Veerman AJ, Sutaryo, Purwanto I, Vd Ven PM, Cloos J. Myeloid Antigen Expression in Childhood Acute Lymphoblastic Leukemia and Its Relevance for Clinical Outcome in Indonesian ALL-2006 Protocol. J Oncol. 2012;2012:13518610.1155/2012/135186351375223227046]Search in Google Scholar
[18. Griesinger F, Elfers H, Ludwig WD, Falk M, Rieder H, Harbott J, et al. Detection of HRX-FEL fusion transcripts in pre-pre-B-ALL with and without cytogenetic demonstration of t(4;11). Leukemia. 1994 Apr;8(4):542-8]Search in Google Scholar
[19. Behm FG, Smith FO, Raimondi SC, Pui CH, Bernstein ID. Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements. Blood. 1996 Feb 1;87(3):1134-910.1182/blood.V87.3.1134.bloodjournal8731134]Search in Google Scholar
[20. Borowitz MJ, Béné M-C, Harris NL, Porwit A, Matutes E. Acute leukaemias of ambiguous lineage. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: WHO Press; 2008. p. 150-5]Search in Google Scholar
[21. Béné MC, Porwit A. Acute leukemias of ambiguous lineage. Semin Diagn Pathol. 2012 Feb;29(1):12-810.1053/j.semdp.2011.08.00422372202]Search in Google Scholar
[22. Béné MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995;9:1783-6]Search in Google Scholar
[23. Catovsky D, Matutes E, Buccheri V, Shetty V, Hanslip J, Yoshida N, et al. A classification of acute leukaemia for the 1990s. Ann Hematol 1991;62:16-2110.1007/BF017149782031964]Search in Google Scholar
[24. Chen CS, Sorensen PH, Domer PH, Reaman GH, Korsmeyer SJ, Heerema NA, et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood. 1993 May 1;81(9):2386-9310.1182/blood.V81.9.2386.bloodjournal8192386]Search in Google Scholar
[25. Rubnitz JE, Link MP, Shuster JJ, Carroll AJ, Hakami N, Frankel LS, et al. Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1994 Jul 15;84(2):570-310.1182/blood.V84.2.570.570]Search in Google Scholar
[26. van der Linden MH, Creemers S, Pieters R. Diagnosis and management of neonatal leukaemia. Semin Fetal Neonatal Med. 2012 Aug;17(4):192-510.1016/j.siny.2012.03.00322510298]Search in Google Scholar
[27. Zhang Y, Wu D, Sun A, Qiu H, He G, Jin Z, et al. Clinical characteristics, biological profile, and outcome of biphenotypic acute leukemia: a case series. Acta Haematol. 2011;125(4):210-810.1159/00032259421266800]Search in Google Scholar
[28. Hughes TP, Morgan GJ, Martiat P, Goldman JM. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood. 1991;77(4):874-810.1182/blood.V77.4.874.874]Search in Google Scholar
[29. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N, et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia. 2003 Dec;17(12):2318-5710.1038/sj.leu.240313514562125]Search in Google Scholar
[30. Gerr H, Zimmermann M, Schrappe M, Dworzak M, Ludwig WD, Bradtke J, et al. Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations. Br J Haematol. 2010 Apr;149(1):84-9210.1111/j.1365-2141.2009.08058.x20085575]Search in Google Scholar
[31. Sakaki H, Kanegane H, Nomura K, Goi K, Sugita K, Miura M, Ishii E, Miyawaki T. Early lineage switch in an infant acute lymphoblastic leukemia. Int J Hematol 2009; 90: 653-510.1007/s12185-009-0446-719936875]Search in Google Scholar
[32. Stasik C, Ganguly S, Cunningham MT, Hagemeister S, Persons DL. Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia. Cancer Genet Cytogenet 2006; 168: 146-9 10.1016/j.cancergencyto.2006.02.01316843104]Search in Google Scholar
[33. Jiang JG, Roman E, Nandula SV, Murty VV, Bhagat G, Alobeid B. Congenital MLL-positive B-cell acute lymphoblastic leukemia (B-ALL) switched lineage at relapse to acute myelocytic leukemia (AML) with persistent t(4;11) and t(1;6) translocations and JH gene rearrangement. Leuk Lymphoma 2005; 46: 1223-710.1080/1042819050008605516085566]Search in Google Scholar
[34. Park M, Koh KN, Kim BE, Im HJ, Jang S, Park CJ, Chi HS, Seo JJ. Lineage switch at relapse of childhood acute leukemia: a report of four cases. J Korean Med Sci. 2011 Jun;26(6):829-3110.3346/jkms.2011.26.6.829310288021655072]Search in Google Scholar
[35. Lou Z, Zhang CC, Tirado CA, Slone T, Zheng J, Zaremba CM, Oliver D, Chen W. Infantile mixed phenotype acute leukemia (bilineal and biphenotypic) with t(10;11) (p12;q23);MLL-MLLT10. Leuk Res. 2010 Aug;34(8):1107-9 10.1016/j.leukres.2010.02.02920299091]Search in Google Scholar